The big winners at last week’s Emmy Awards expressed their gratitude to their agents, managers, and audiences, but several stars had one notable donor that went without much thanks: the injectable drug semaglutide, which is branded as ozempic,
The drug is an insulin regulator for pre-diabetes, made by Danish pharma juggernaut Novo Nordisk, whose primary side effect is dramatic weight loss. It has saturated the industry in recent months, helping the handsome and wealthy shed extra pounds in never-ending Los Angeles entertainments of adaptations of appearances. Hollywood nutritionist Matt Mahowald told Diversity The main benefits of that injection are “to reduce and draw back insulin secretion, and to slow your stomach emptying. It promotes satiety from food.”
A top powerbroker told Diversity That last week half of her call sheet was filled with friends and clients who wanted to discuss Ozempic’s risks, which has claimed devotees from every corner of the industry. Moguls, reality starlets, veteran filmmakers and, of course, actors are silently singing the praises of the drug on Signal, the encrypted messaging app mostly used for confidential conversations. Hair, make-up and styling teams for celebrities have come to take injections as part of grooming rituals ahead of major events. In just a few months, it’s become a worst-kept secret in Hollywood—especially considering that its most ardent users aren’t pre-diabetic and don’t need medication. It is currently being supplied by doctors and nutritionists, although rumor has it that you can score the drug at medical spas in Arizona as well. Naturally, it is not cheap.
“It’s easily going to be $1,200 to $1,500 a month. If you go out and buy an Ozempic pen from a pharmacist, that’s what you’re being charged,” Mahowald says.
However, the swift response from industry types has created a headache for major insurers.
“It’s become a big problem, everyone is jumping on this bandwagon. Insurance companies are refusing to cover it for someone who doesn’t have diabetes. It’s a panic. Back to pharmacies through December There are units on order,” Mahowald says.
What is more worrying, according to several reports, is a huge demand leaving those who need injections battling short supplies. Another version of semaglutide called Wegovi, which specifically targets obesity, is also making the rounds and is hardly available.
The drug made international headlines three months ago after it went viral on TikTok, as the trend #MyOzempicJourney showed an eye change (The Guardian). informed of The #Ozempic hashtag was viewed 74 million times across the platform). Earlier this month, Town & Country wrote A dispatch claiming the drug was the talk of coastal dinner parties. glamor magazine followed suit.
“Obesity is an epidemic,” warns Dr. Zhaoping Li, chief of clinical nutrition at the David Geffen School of Medicine at UCLA. “The point is, this is a tool in our box, it’s not the end. The longest study on these injections was done in less than two years. A lot of questions haven’t been answered.”
Dr. Lee said that the maximum weight loss shown in most patients is 15% of body mass, which brings us back to the terrifying truth that Hollywood’s resourceful people hate to hear: “It’s about lifestyle comes down. activity, healthy eating habits and stress management.”
Like any miracle weight loss drug, there are doubts about long-term use. In addition to a lean figure, a notable side effect is “gastrointestinal phenomena – bloating, constipation, diarrhea,” according to Town & Country.
When asked about this unpleasant risk, one talent campaigner bluntly said: “Who cares? Everyone who works in this business has IBS anyway.”